David M Cognetti
Overview
Explore the profile of David M Cognetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
788
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Philips R, Alnemri A, Amin D, Patel J, Topf M, Johnson J, et al.
Cancer
. 2023 Oct;
130(6):863-875.
PMID: 37788128
Background: There is sparse literature on the effect of preoperative immunotherapy on complications after surgery for primary head and neck squamous cell carcinoma (HNSCC). The objectives are to compare complication...
12.
Johnson J, Vathiotis I, Harshyne L, Ali A, Bar Ad V, Axelrod R, et al.
J Immunother Cancer
. 2023 Aug;
11(8).
PMID: 37536941
Background: The combination of nivolumab and ipilimumab has been approved for the treatment of multiple solid tumors. This was a phase I study investigating definitive radioimmunotherapy (RIT) with nivolumab and...
13.
Amin D, Philips R, Bertoni D, Mastrolonardo E, Campbell D, Agarwal A, et al.
JAMA Otolaryngol Head Neck Surg
. 2023 Jul;
149(11):980-986.
PMID: 37422846
Importance: Due to lack of data from high-powered randomized clinical trials, the differences in functional and survival outcomes for patients with oropharyngeal squamous cell carcinoma (OPSCC) undergoing primary transoral robotic...
14.
Hill B, Calder A, Flemming J, Guo Y, Gilmore S, Trofa M, et al.
Mol Carcinog
. 2023 Jul;
62(9):1428-1443.
PMID: 37401875
Therapy using anti-PD-1 immune checkpoint inhibitors (ICI) has revolutionized the treatment of many cancers including head and neck squamous cell carcinomas (HNSCC), but only a fraction of patients respond. To...
15.
De Ravin E, Armache M, Campbell F, Rising K, Worster B, Handley N, et al.
Otolaryngol Head Neck Surg
. 2023 Mar;
168(6):1312-1323.
PMID: 36939546
Objective: Evaluate the feasibility and cost-effectiveness of telehealth head and neck cancer (HNC) survivorship care. Data Sources: Ovid MEDLINE, Embase, Scopus, CINAHL. Review Methods: A systematic search for peer-reviewed feasibility...
16.
Campbell D, Xiao K, Mastrolonardo E, Cognetti D
Laryngoscope Investig Otolaryngol
. 2023 Feb;
8(1):82-88.
PMID: 36846427
Objectives: Patients are increasingly relying on YouTube for health information. We objectively evaluated the quality and comprehensiveness of sialendoscopy YouTube videos available to patients. We further investigated the relationship between...
17.
Sussman S, Philips R, Renslo B, Givens A, Swendseid B, Tassone P, et al.
Otolaryngol Head Neck Surg
. 2022 Aug;
168(4):782-789.
PMID: 35943815
Objective: To assess whether preoperative tracheostomy (PreOT) increases risk of complications after total laryngectomy (TL) and to determine if timing of tracheostomy creation is associated with an increased risk. Study...
18.
Gulati A, Cognetti D, Cohen D, Ogden M, Schaitkin B, Walvekar R, et al.
Laryngoscope
. 2022 Jun;
133(3):539-546.
PMID: 35694724
Objective: The Chronic Obstructive Sialadenitis Symptoms questionnaire (COSS) was created to assess chronic sialadenitis symptoms and treatment response, but its development lacked patient input and validation. We analyzed COSS responses...
19.
Alnemri A, Philips R, Sussman S, Xu V, Givens A, Patel A, et al.
Head Neck
. 2022 Jun;
44(8):1896-1908.
PMID: 35665975
Background: Outcomes and cost of soft tissue versus bony midface free flap reconstruction (MR) with and without virtual surgical planning (VSP) were evaluated. Methods: Retrospective review of MR including ischemic...
20.
Mastrolonardo E, Campbell D, Stewart M, Swendseid B, Thaler A, Curry J, et al.
Am J Otolaryngol
. 2022 May;
43(4):103483.
PMID: 35580419
Objective: To compare the experiences of patients who received sialendoscopy under general anesthesia (GA) with those who received monitored anesthesia care (MAC). Methods: Patients who underwent sialendoscopy for sialadenitis or...